https://www.msn.com/en-ie/news/coronavirus/uk-paid-dollar20-million-for-new-coronavirus-tests-they-didnt-work/ar-BB12LAxf?ocid=spartandhpThe New York Times. on the UK government spending $20 on Covid-19 test kits that failed to work.


London — The two Chinese companies were offering a risky proposition: two million home test kits said to detect antibodies for the coronavirus for at least $20 million, take it or leave it.

The asking price was high, the technology was unproven and the money had to be paid upfront. And the buyer would be required to pick up the crate loads of test kits from a facility in China.

Yet British officials took the deal, according to a senior civil servant involved, then confidently promised tests would be available at pharmacies in as little as two weeks. “As simple as a pregnancy test,” gushed Prime Minister Boris Johnson. “It has the potential to be a total game changer.”

There was one problem, however. The tests did not work.

Continue reading @ The New York Times.

U.K. Paid $20 Million For New Coronavirus Tests ➤ They Didn’t Work

https://www.msn.com/en-ie/news/coronavirus/uk-paid-dollar20-million-for-new-coronavirus-tests-they-didnt-work/ar-BB12LAxf?ocid=spartandhpThe New York Times. on the UK government spending $20 on Covid-19 test kits that failed to work.


London — The two Chinese companies were offering a risky proposition: two million home test kits said to detect antibodies for the coronavirus for at least $20 million, take it or leave it.

The asking price was high, the technology was unproven and the money had to be paid upfront. And the buyer would be required to pick up the crate loads of test kits from a facility in China.

Yet British officials took the deal, according to a senior civil servant involved, then confidently promised tests would be available at pharmacies in as little as two weeks. “As simple as a pregnancy test,” gushed Prime Minister Boris Johnson. “It has the potential to be a total game changer.”

There was one problem, however. The tests did not work.

Continue reading @ The New York Times.

No comments